Alex Azar, Former Pharmaceutical Executive, Nominated to Lead HHS

President Trump has nominated Alex Azar to lead the U.S. Department of Health and Human Services (HHS), which would include oversight of the National Institutes of Health (NIH) and the Agency for Healthcare Research and Quality (AHRQ), among other federal agencies. Azar served as general counsel and deputy secretary to the Department under the George W. Bush administration and served as the president of Lilly Co., part of the pharmaceutical company Eli Lilly and Co., until earlier this year. Azar’s nomination comes following former HHS Secretary Tom Price’s resignation after news surfaced of improper use of private jets for government business. Azar must be confirmed by the Senate; no date for a confirmation hearing has been announced at this time.

Back to this issue’s table of contents.

Tagged with: , ,
Posted in Issue 22 (November 14), Update, Volume 36 (2017)


Click here to subscribe to the COSSA Washington Update, our biweekly newsletter.


Looking for something from a previous issue of the COSSA Washington Update? Try our archive.


Browse by Month